心血管疾病中的三维生物打印:当前状态和未来方向
Zhonghua Sun1,2, Jack Zhao3, Emily Leung3
1Discipline of Medical Radiation Science, Curtin Medical School, Curtin University, Perth, WA 6102, Australia.
Biomolecules
|August 26, 2023
概括
三维 (3D) 生物打印为心血管疾病提供了先进的解决方案,可以创建功能性组织和器官. 这项技术有望修复受损的心脏组织和血管,进步再生医学.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 心血管科学 心血管科学
背景情况:
- 三维 (3D) 打印在心血管疾病中至关重要,为教育和手术规划提供准确的个性化模型.
- 3D生物打印通过使细胞组件,组织和器官用于心血管应用进行打印来推进这项技术.
研究的目的:
- 审查心血管疾病中的3D生物打印现状和未来潜力.
- 专注于心脏组织,血管结构,心脏门和心肌中的应用.
主要方法:
- 关于3D生物打印技术近期进展的综述.
- 在创建血管化结构,心脏组织和心脏门方面的应用分析.
主要成果:
- 3D生物打印展示了大型结构的血管化潜力,提高了生物相容性和稳定性.
- 在打印功能性心脏组织,血管移植和心脏门方面的新兴能力.
结论:
- 3D生物打印在心血管疾病中为组织和器官更换提供了显著的机会.
- 需要进一步的研究来解决局限性,并充分实现这项技术的潜力.
相关概念视频
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


